Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,563
in 6 filings

Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-10 Kamdar Kim P. Director Grant or award +22,426 54,999
2026-07-10 Kamdar Kim P. Director Grant or award +3,421 58,420
2026-07-10 Kamdar Kim P. Director Grant or award · Stock Option (right to buy) +34,494 34,494
2026-07-10 Kamdar Kim P. Director Grant or award · Stock Option (right to buy) +5,263 5,263
2026-02-04 Kamdar Kim P. Director Other disposition −30,920 0
2026-02-04 Kamdar Kim P. Director Other acquisition +3,231 32,573
2025-06-05 Kamdar Kim P. Director Grant or award +15,596 29,342
2025-06-05 Kamdar Kim P. Director Grant or award · Stock Option (right to buy) +25,000 25,000
2024-06-06 Kamdar Kim P. Director Grant or award +7,117 13,746
2024-06-06 Kamdar Kim P. Director Grant or award · Stock Option (right to buy) +10,549 10,549
2023-06-08 Kamdar Kim P. Director Grant or award · Stock Option (right to buy) +63,265 63,265
2022-06-03 Kamdar Kim P. Director Grant or award · Stock Option (right to buy) +149,675 149,675

Page 1 of 1 · 12 trades